




PSYCHOACTIVE SUBSTANCE DEPENDENCE IN FEMALES.  A 
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ABSTRACT. 
Background : Psychoactive Substance dependence  is a chronic and relapsing brain disorder 
characterized by uncontrollable drug use despite negative physical, social and psychological 
consequences. Although regarded as a mainly male affair in the past, recent trends indicate that 
more females are becoming involved.  
 
Materials and Method: Data was collected from the case notes of all patients admitted into 
Centre for Addiction treatment Vom between January 2014 and December 2016 . Data was 
analyzed using SPSS 16.0 .  
 
Results. There was a progressive increase in the number of female admissions. Their ages range 
from 16 to 47 years and 88.9 % were multiple substance abusers. Psycho-stimulants were the 
commonest substance of abuse among the females with a high rate of abuse of prescription 
medications, the commonest being tramadol. Injecting drug use was uncommon. 
 
Conclusion:  Females are increasingly becoming involved in substance use. 
 
Key words:. Psychoactive substance dependence, females, admission, drug treatment centre, 
North central Nigeria. 
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sychoactive substance use, until 
recently, has largely been perceived 
as a male problem and research, as a 
result, has been largely androcentric and 
insensitive to gender variations. 
Historically, women using substance have 
always been frowned upon.  Rules on 
acceptability dates back as far as laws of 
Hammurabi
1
 in the west and the 
Manusmriti in India which states that, “a 
wife who drinks wine … may be 
abandoned at any time.”
2 
 
In the past, many studies have consistently 
shown a gender difference among people 
who abuse psychoactive substances, those 
who develop dependence as well as those 
seeking and entering treatment for 
substance dependence with males having 
consistently higher rates than females
3
 
More recently, epidemiologic surveys 
suggest that this gap between men and 
women has narrowed.
4,
  For example, The 
epidemiological catchment area (ECA)  
surveys in the early 1980s estimated the 
male/female ratio of alcohol-use disorders 
as 5:1,
5
whereas  more recent surveys  
report a narrower gap between males and 
females with a ratio of approximately 3:1.
6 
The National Epidemiologic Survey on 
Alcohol and Related Conditions showed 
that men were more likely to have drug 
dependence.
3
 Other studies indicate that 
rates of nonmedical prescription drug use 
are higher among women than men, 
particularly for narcotic analgesics and 
tranquilizers,
7
 other studies report 
equivalent or higher rates among men.
8
 
An accelerated progression from the 
initiation of substance use to the onset of 
dependence and first admission to 
treatment among women especially for 
opioids, cannabis, and alcohol, a 
phenomenon called  “telescoping” have 
been  reported by several studies
9-11
 . This 
phenomenon has been consistently 
observed in investigations of gender and 
substance-use disorders. 
Substance abuse among females in Nigeria 
has been the focus of some studies. For 
instance, studies conducted on 725 
students of nine randomly selected female 
senior secondary schools, 3 each from the 
three senatorial zones of Anambra state  
Nigeria on substance abuse among females  
by Egbuonu et al (2004)
 12
  found that 
4.7% of the girls smoked tobacco 
(cigarette) while 9.5% indulged in alcohol 
and 15% took sedatives as a means of 
inducing sleep.    
 
With regards to drug abuse, even pregnant 
women in Nigeria are no exception. 
Nyango et al (2012)
13
 studied 557 
antenatal patients at Jos University 
Teaching Hospital, they found the 
prevalence rate of substance use among 
the pregnant women to be 43.8%. 
Furthermore, the prevalence rates for 
various substances were as follows: 
alcohol 8.6%, diazepam 4.5% , 
cigarettes/tobacco 2.9%, cocaine 2.5%, 
codeine 2.0%, and marijuana 1.6%. 
There are rarely any studies specifically on 
female patients on admission for drug 
dependence treatment in our society. The 
objectives of this study is to determine the 
socio demographic profile of female 
patients on admission and assess  
substance abuse trends among them and 
also identify the types of substances used. 
MATERIALS AND METHODS 
The Centre for Addiction Treatment and 
Research (CATR) Vom is located within 
the premises of Vom Christian Hospital, 
Vom, Plateau State. It receives patients 
mainly from within plateau state but also 
from neighboring states such as 
Nassarawa, Bauchi, Kaduna, Gombe, 
Taraba, FCT as well as from other states.  
 
This was a retrospective study of patients 
admitted in the Centre for Addiction 
treatment and research between January 




permission from management of CATR 
Vom, socio- demographic data was 
collected from case notes of all patients  ( 
males and females). Furthermore, 
additional data on psychoactive substance 
use was collected from case records of all 
female patients admitted to the centre 
within the period of the study  i.e 2014 to 
2016. Data on injecting drug use was also 
collected from case notes of all patients 
with a history of injecting drug use. 
 




There was a progressive increase in the 
number of females on admission although 
they were consistently fewer than the 
males throughout the three year period of 
the study with the highest proportion of 
13.8% females recorded in 2015.  Their 
ages range from 16 to 47 years old. An 
overwhelming majority ( 88.9 % ) of them 
were multiple substance abusers. Among 
the various psychoactive substances used, 
psycho-stimulants were the commonest 
substance of abuse among the females. 
Duration of substance use ranged from 1 




















Majority of the females were single 
(73.3% )  and unemployed (60%). The 
commonest route of drug use was the oral 
route (58%). There was no report of per 
rectal use of the drugs. Injecting drug use 
(IDU) was rare with only two female 
patients reporting they injected 
pentazocine.  Age (ᵡ 
2
 =6.73. p=0.001) as 
well as educational status (ᵡ 
2 
=74.8.  
p=0.0001) were significantly associated 
with injecting drug use. 
 
Although a few patients had a chaotic drug 
use history which made it difficult to 
determine the primary drug in their cases, 
Overall, in the three year period, the three 
most common primary drug of abuse in 
these patients was Tramadol ( 42.2%), 
marijuana(38.3%) and alcohol (14.9%). 
 
Some of the patients had co-morbid  
mental disorders, others had co-morbid 
physical and    mental disorders along with 
their substance use disorder.   The most 
common co-morbid mental disorder was 
depression. Co-morbid physical disorders 
include hypertension, UTI,  epilepsy, 




Table 1. Socio demographic profiles of the female patients. 
 
Variable N(%) 






















































Table 2. Comparison of socio demographic characteristics of injecting drug users (IDUs) 
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Females were consistently among patients 
on admission for drug addiction and in  
2015, they constituted 13.8% of all patients 
on admission, the highest for the period of 
the study.  McHugh and his colleagues in a 
recent 2012 study amongst 41.5 million 
illicit drug users, found more than 42% were 
women, suggesting a male/female ratio of 
1.4:1 at the present time.
14
 In case of 
prescription drug abuse, several studies 
actually report their use to be higher in 




We found a low proportion of females 
among the patients on admission thus:  7.1%  
in 2014, 13.8%  in 2015 and 11.7% in 2016. 
This is possibly an indication that not many 
females are involved in drug abuse in our 
environment but it may also indicate that 
fewer females get into treatment. Many 
studies have attested to this.  Greenfield et al 
(2007)
16
 reviewed the literature between 
1975 and 2005 and concluded that women 
are less likely to enter substance abuse 
treatment than men despite their increasing 
participation in drug abuse. Many western 
studies indicate that relatively low 
proportion of women enter substance abuse 
treatment programs.
17,18
 The ratio of 
treatment seeking men to women was found 
to be 3.3:1 in alcohol treatment facilities 
while, for that time-period, the male/female 
ratio of alcohol use disorders in the 
population was estimated to be 2.7:1
19,20. 
 
This study found that the use of prescription 
medication was fairly common: Tramadol 
was the commonest and was abused by 75% 
of the patients admitted , diazepam 25% and  
pentazocine  8.3% .  Our results, differ 
slightly from the findings of a study in India 
by  Dayan and Balhara
21
  who studied Case 
records of all female patients admitted with 
substance use disorder at a national level 













India between January 2008 and December 
2012. They found that 39% of the women on 
admission used prescription opioids and 
36% used prescription opioid along with 
benzodiazepines. The commonest 
prescription opioid was pentazocine used by 
87 % of the women. Whereas the Indian 
study found pentazocine to be the 
commonest prescription opiod used by 87 % 
of their patients, in contrast, we found 
tramadol to be the commonest prescription 
opiod abused by 75% of the females in our 
study. 
The primary drug refers to the drug causing 
the most problem in the patient or the drug 
responsible for the current admission. We 
found the commonest primary drugs for the 
three year period to be tramadol 42.2%, 
marijuana 38.3% and alcohol 14.9%. Data 
from the Nigerian epidemiological network 
on drug use (NENDU)
22  
show that the 
commonest primary drug for both males and 
females are cannabis 36%, opiates 28% and 
alcohol 17%.  
Substance abuse is commonly co- morbid 
with other disorders
21
. Our study found that 
the commonest co morbid disorder among 
the females was depression. Other co-
morbid disorders include  UTI, 
hypertension, Tonic clonic generalized 
epilepsy, HIV/AIDS and dyspepsia .   
CONCLUSION 
There is an increasing number of females 
being involved in abuse of drugs with high 
rates of abuse of prescription medication( 
tramadol). Multiple drug use is common 
including  injecting drug use with co-morbid 
conditions such as HIV.AIDS recorded in 
some patients. Drug treatment centers 
should endeavour to provide facilities for 
female clients as well. 
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